Biography
David Dowdy is a Professor of Epidemiology and the Executive Vice Dean for Academic Affairs at the Johns Hopkins Bloomberg School of Public Health. Dr. Dowdy is trained in infectious disease epidemiology and general internal medicine and has been studying the epidemiology of tuberculosis for nearly 25 years. His primary expertise is in evaluating the cost-effectiveness, implementation, and population-level impact of interventions to fight tuberculosis worldwide.
Key Impacts
Cost effectiveness of 1HP vs 3HP in HIV-negative contact persons with latent TB infection in Brazil
Due to its shorter regimen duration and similar safety events, 1HP presents a more cost-effective alternative to 3HP for adults exposed to TB in their homes. Combined with the UltraCurto safety results, these findings support the wider adoption of 1HP for TB prevention in the adult population. Future research should explore safety and cost-effectiveness of 1HP in other populations including children and pregnant and lactating persons.
Source: Conference 2024